Banagan, Reymark .
HRN: 27-39-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/02/2025
07/09/2025
IV
4.5g
Q8
Pneumonia
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines